Breaking News, Promotions & Moves

Frontage Expands Business in Canada with New Leadership

Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will spearhead growth as he continues to serve as Chief Scientific & Strategy Officer.

By: Rachel Klemovitch

Assistant Editor

Frontage Holdings Corporation has appointed Dr. Abdul Mutlib as the President of Frontage Laboratories, Canada. Mutlib will spearhead Frontage’s growth in the Canadian market and continue to serve as the Chief Scientific & Strategy Officer for Frontage Laboratories.  This appointment reflects Frontage’s commitment to enhancing and expanding its services as a leading global pharmaceutical CRO. Mutlib brings over 35 years of R&D experience in large pharmaceutical and CRO ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters